Optime Care offers a patient-first suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders
BioMatrix offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions
BioMatrix broadens their reach in key therapeutic categories with new payer contracts adding additional covered lives
Trodelvy is the first anti-Trop-2 ADC recently approved by the FDA for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease
Founded in 1994, US Bioservices began as a regional pharmacy focused on infused therapies. Building on a foundation of patient-centered care, it now provides national in-home nursing services and clinical support for thousands of patients with chronic and complex illnesses. US Bioservices was acquired by AmerisourceBergen in 2003. US Bioservices works in collaboration with other […]
Specialty Drug Spend Under the Medical Benefit — Biologic, biotechnology based, rare disease or high cost pharmaceuticals—collectively known as specialty drugs—can be covered under the pharmacy benefit, the medical benefit, or both depending on the plan sponsors’ benefit design required of the payor. On average, up to 50% of specialty drugs are covered under the […]